PTCA / bypass surgery / coronary artery bypass surgery / percutaneous transluminal coronary angioplasty / thrombolytic therapy / amputation / Alternative therapies / balloon occlusion / sham treatment / /
Organization
Food and Drug Administration / Medical Devices Advisory Committee / New York Heart Association / Division of Epidemiology / FDA / Cardiovascular Devices Office / Device Evaluation Center for Devices / /
FDA Executive Summary Prepared for the December 5, 2012 meeting of the Circulatory System Devices Panel Classification of External Counter-Pulsating (ECP) Devices (21 CFR[removed])